Hikma Pharmaceuticals Profile

15.3
USD 0.05  0.33%
15.25Last Month High 15.65 
15.3Trading Day  High 15.3 

Hikma Pharmaceuticals Summary

Hikma Pharmaceuticals PLC (HKMPF) is traded on OTC Market in USA. It is located in 13 Hanover Square, London W1S 1HW, United Kingdom and employs 7,189 people. The company currently falls under 'Mid-Cap' category with current market capitalization of 3.63 B. Hikma Pharmaceuticals PLC has 0 outstanding shares. HIKMA PHARMACEUTI has accumulated about 265 M in cash with 419 M of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.1.
Check Hikma Pharmaceuticals Probability Of Bankruptcy

Hikma Pharmaceuticals PLC Risk Profiles

Key Fundamentals

Hikma Pharmaceuticals Against Markets

Current Ratings  

Hikma Pharmaceuticals 30 Days Performance Scores
Risk Adjusted
Performance Score (0 to 100)
0 
Chance of
< 35% 
Hikma Pharmaceuticals PLC develops, manufactures, and markets a range of branded and nonbranded generic and inlicensed pharmaceutical solutions in solid, semisolid, liquid, and injectable final dosage forms in the Middle East and North Africa, the United States, Europe, the United Kingdom, and internationally. more
NameHikma Pharmaceuticals PLC
Analyst Consensus
Macroaxis Advice
InstrumentUSA Stock Stocks Directory
Business Address13 Hanover Square, London W1S 1HW, United Kingdom
ExchangeOTC Market
BenchmarkDOW
Websitewww.hikma.com
Contact Number(44) 20 7399 2761
CurrencyUSD - US Dollar

Directors

Hikma Pharmaceuticals Corporate Directors
Pamela Kirby Non-Executive Independent Director, Ph.D
John Castellani Non-Executive Independent Director
Ali AlHusry Non-Executive Director, MBA

Opportunities

Explore Investment Opportunities
Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked.
Explore Investing Ideas